Halley E. Gilbert - 31 Dec 2021 Form 5 Insider Report for NEOGENOMICS INC (NEO)

Signature
/s/ Halley E. Gilbert
Issuer symbol
NEO
Transactions as of
31 Dec 2021
Net transactions value
+$5,540
Form type
5
Filing time
08 Feb 2022, 18:12:44 UTC
Previous filing
30 Dec 2021
Next filing
03 Mar 2022

Key filing fact

Halley E. Gilbert filed Form 5 for NEOGENOMICS INC (NEO) on 08 Feb 2022.

Key facts

  • This page summarizes Halley E. Gilbert's Form 5 filing for NEOGENOMICS INC (NEO).
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 08 Feb 2022, 18:12.

Change

  • Previous filing in this sequence was filed on 30 Dec 2021.
  • Current net transaction value: +$5,540.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC Source

Ownership activity is grounded in SEC Form 5 disclosures.

See Original Filing

Reported transactions

NEO transaction

Common Stock

Small acquisition under Rule 16a-6

Transaction value
$5,540
Shares
+177
Change %
+0.17%
Price
$31.30
Shares after
105,263
Date
31 Dec 2021
Ownership
Direct
Footnotes
F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
63,331
Date
31 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
63,331
Exercise price
$42.21
Footnotes
F2
An asterisk next to the price means the reported price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the year ended December 31, 2021. The shares were acquired in transactions exempt from Section 16b-3.
F2 On August 17, 2021, Ms. Gilbert was granted 63,331 stock options. These options vest ratably over the first four anniversary dates of the grant date.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .